Turps Id suggest you call David Segal at POH re these queries. This information has never been released so Im not sure what kind of info Segal can share. GC is correct that the OxyC Topical trial commencing next Quarter will be short and cheap ( it has been suggested less than $900k by some) however the OxyM trial will be a large and expensive one.
- Forums
- ASX - By Stock
- AVE
- Chart, Cash and Scenarios
Chart, Cash and Scenarios, page-27
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $1.32K | 440K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
30 | 40522233 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 40065430 | 31 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 40522233 | 0.002 |
32 | 75717741 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 39315430 | 30 |
0.004 | 30596565 | 18 |
0.005 | 10575266 | 9 |
0.006 | 10908952 | 10 |
0.007 | 13396103 | 7 |
Last trade - 14.05pm 15/11/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online